Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from CymaBay Therapeutics (CBAY).
CymaBay Therapeutics, Inc. has made significant changes to its executive officers’ employment agreements, removing certain clauses related to severance payments and introducing provisions for a tax make-whole payment. This move aims to address potential excise taxes on executive compensation, ensuring that their executives are not financially penalized for these taxes under the updated tax laws.
Learn more about CBAY stock on TipRanks’ Stock Analysis page.